Revolution Medicines, Inc. (42Z)
XDUS
Closed
Oct 8, 2026
Day's Range
177.8552 wk Range
39.40Overview - 42Z - Revolution Medicines, Inc.
Key Statistics
Valuation
Enterprise Value
-225.04M
P/E (Trailing)
‪-30.43‬
PEG Ratio
‪-0.22‬
Price / Book
‪14.65‬
EV / EBITDA
‪0.20‬
Profitability
Return on Assets
‪-48.04%‬
Return on Equity
‪-69.34%‬
Ownership
Shares Outstanding
214.24M
Price stats
50-Day Avg
‪172.40‬
200-Day Avg
‪122.80‬
Peers - 42Z - Revolution Medicines, Inc.
Peer Comparison
Compared with companies in Biotechnology listed on XDUS.
- 42ZXDUSRevolution Medicines, Inc.+78.13%52-week change-30.44P/E (Trailing)—Profit Margin
- 0QFXDUSModerna Inc.+85.69%52-week change—P/E (Trailing)—Profit Margin
- 2LBXDUSIovance Biotherapeutics Inc.+83.47%52-week change-10.55P/E (Trailing)‪34.27%‬Profit Margin
- 3920XDUSSpyre Therapeutics, Inc.+82.13%52-week change-37.88P/E (Trailing)—Profit Margin
- 0MEXDUSTwist Bioscience Corporation+80.08%52-week change-108.42P/E (Trailing)‪50.72%‬Profit Margin
- 3O8XDUSOmeros Corp.+77.85%52-week change-333.00P/E (Trailing)—Profit Margin
- 7BGXDUSOncoinvent ASA+76.57%52-week change-0.06P/E (Trailing)—Profit Margin
Profile Summary - 42Z - Revolution Medicines, Inc.
About
Revolution Medicines, Inc. is a clinical-stage precision oncology company focused on developing targeted therapies for RAS-addicted cancers. The company applies proprietary drug discovery capabilities to create small-molecule medicines designed to act on challenging RAS pathway targets, a central driver in many…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
